One of Edwards Lifesciences Corp (NYSE:EW)’s Board members purchased 2,000 shares on April 26th at an average price of $64.95 per share. The $7.1 billion market cap medical device company specializes in heart valves and other cardiovascular products. Pretax income grew by 27% last quarter compared to the first quarter of 2012, though revenue growth was only 8% and so we would be a bit concerned as to how sustainable its bottom-line growth rate is. Sectoral Asset Management was one major shareholder of Edwards Lifesciences Corp (NYSE:EW) according to that fund’s most recent 13F filing (research more stocks Sectoral owned).
Disclosure: I own no shares of any stocks mentioned in this article.